Foster common approaches between People’s Republic of China and the European Union on Personalised Medicine research, development, innovation and policies
News
IC2PErMed new publication in Open Access Government Journal – Check it out !
We are happy to announce that IC2PerMed’s article “Fostering collaboration between Europe and China to enhance Personalised Medecine" [...]
New IC2PerMEd deliverable online
We are delighted to inform you that IC2PerMed public deliverable report on the High Level Symposium that [...]
Two new scientific publications are available
We are delighted to announce you that two scientific publications are now available! These papers were developped in [...]
IC2PerMed at a glance
Supporting International collaboration for the development of Personalised Medicine
The International Consortium for Personalised Medicine (ICPerMed), umbrella initiative of IC2PerMed, aims at initiating and supporting communication and exchange on Personalised Medicine (PM) for aligning national agendas on research and funding activities. It brings together representatives of funding agencies and authorities from 29 countries and expands for increasing PM developments’ synergies at international level.
IC2PerMed project’s core objective is to build upon collaborative developments of Chinese and European experts on PM for elaborating a common strategy, enabling Chinese institutions to join the ICPerMed consortium. The 3 Expert Working Groups will set the path for a common approach of PM research, innovation, development and implementation over the project duration.
